Skip to main content

Table 1 Detailed patient characteristics

From: Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls

Time of diagnosis

(months)

Patient

Age at diagnosis (months)

Current age (years)

Duration of NTBC treatment (years)

Clinical problems at diagnosis

≤2

1

0,3

9,2

9,1

pre-symptomatically

2

0,03

14,0

14,0

3

0,03

15,3

15,3

4

0,2

8,1

8,0

5

0,03

15,6

15,6

6

0,1

12,1

12,1

7

0,1

10,3

10,3

8

0,5

10,4

10,4

9

0,1

8,8

8,8

10

1,7

10,4

10,2

2–6

11

3,2

7,9

7,6

Acute liver failure and renal tubulopathy

12

4,1

13,4

13,1

Acute liver failure

13

2,9

9,7

9,5

Acute liver failure

14

3,8

9,9

9,6

Acute liver failure

15

3,0

16,0

15,8

Acute liver failure, renal tubulopathy and rickets

16

5,0

17,7

17,3

Renal tubulopathy, nefromegaly and rickets

≥6

17

8,6

23,4

20,6

Liver cirrhosis

18

13,0

7,9

6,7

Liver cirrhosis

19

38,7

23,6

20,4

Liver cirrhosis, renal tubulopathy and rickets